BRAINSTORM CELL THERAPEUTICS INC. Shareholders' Equity
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Shareholders' Equity of -$11.60 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$11.60M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$11.01M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$9.98M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$7.69M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$11.60M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$11.01M 10-Q · filed 2026-08-14 |
| 2025-12-31 | -$9.98M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$7.69M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$6.06M 10-Q · filed 2026-08-14 |
| 2025-03-31 | -$7.46M 10-Q · filed 2026-08-14 |
| 2024-12-31 | -$7.76M 10-Q · filed 2026-08-14 |
| 2024-09-30 | -$6.06M 10-Q · filed 2025-11-14 |
| 2024-06-30 | -$3.53M 10-Q · filed 2025-11-14 |
| 2024-03-31 | -$5.55M 10-Q · filed 2025-11-14 |
| 2023-12-31 | -$4.86M 10-K · filed 2026-03-31 |
| 2023-09-30 | -$2.58M 10-Q · filed 2024-11-14 |
| 2023-06-30 | -$3.88M 10-Q · filed 2024-11-14 |
| 2023-03-31 | -$4.84M 10-Q · filed 2024-11-14 |
| 2022-12-31 | -$3.02M 10-K · filed 2025-03-31 |
| 2022-09-30 | $1.39M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $7.85M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $14.49M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $19.34M 10-K · filed 2024-04-01 |
| 2021-09-30 | $24.93M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $30.17M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $36.20M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $35.46M 10-K · filed 2023-03-30 |
| 2020-09-30 | $25.98M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $9.82M 10-Q · filed 2021-11-15 |
| 2020-03-31 | $9.01M 10-Q · filed 2021-11-15 |
| 2019-12-31 | -$12.22M 10-K · filed 2022-03-28 |
| 2019-09-30 | -$6.78M 10-Q · filed 2020-10-15 |
| 2019-06-30 | -$4.52M 10-Q · filed 2020-10-15 |
| 2019-03-31 | $326.00K 10-Q · filed 2020-10-15 |
| 2018-12-31 | $5.02M 10-K · filed 2021-02-04 |
| 2018-09-30 | $9.98M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $12.87M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $3.83M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $5.88M 10-K · filed 2020-02-18 |
| 2017-09-30 | $5.20M 10-Q · filed 2017-10-17 |
| 2017-06-30 | $7.29M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $8.24M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $9.90M 10-K · filed 2019-04-01 |
| 2016-09-30 | $10.53M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $11.87M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $12.57M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $14.13M 10-K · filed 2018-03-08 |
| 2015-09-30 | $15.52M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $17.84M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $19.66M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $6.67M 10-K · filed 2017-03-29 |
| 2014-09-30 | $8.90M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $10.60M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $860.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $2.74M 10-K · filed 2016-03-09 |
| 2013-09-30 | $4.54M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.35M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $3.48M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $3.98M 10-Q · filed 2015-08-13 |
| 2012-09-30 | $4.46M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $253.00K 10-Q/A · filed 2012-08-29 |
| 2012-03-31 | $817.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $1.49M 10-Q · filed 2014-05-13 |
| 2011-09-30 | $2.34M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $2.25M 10-Q/A · filed 2011-09-07 |
| 2011-03-31 | $2.67M 10-Q · filed 2012-05-11 |
| 2010-12-31 | -$459.00K 10-Q · filed 2014-05-13 |
| 2009-12-31 | -$1.74M 10-Q · filed 2014-05-13 |
| 2008-12-31 | -$2.08M 10-Q · filed 2014-05-13 |
| 2007-12-31 | -$2.43M 10-Q · filed 2014-05-13 |
| 2006-12-31 | -$1.82M 10-Q · filed 2014-05-13 |
| 2006-03-31 | -$7.91M 10-Q · filed 2014-05-13 |
| 2005-03-31 | $704.00K 10-Q · filed 2014-05-13 |
| 2004-03-31 | -$31.00K 10-Q · filed 2014-05-13 |
| 2003-03-31 | $21.00K 10-Q · filed 2014-05-13 |
| 2002-03-31 | $53.00K 10-Q · filed 2014-05-13 |
| 2001-03-31 | $68.00K 10-Q · filed 2014-05-13 |
| 2000-09-24 | $0.00 10-Q · filed 2013-05-09 |
| 2000-09-22 | $0.00 10-Q · filed 2014-05-13 |
| 2000-09-21 | $0.00 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |